Creative Medical Technology Holdings, Inc.

CELZ Biotech & pharma

Develops cell therapies for diabetes and lower back pain.

Jun 2026Revenue $3.00K/yrExpenses $6.24M/yr
No trend
Figures by year

When will Creative Medical Technology Holdings be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.00K and expenses $6.24M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$6.00K$6.15M−$6.14M
Dec 2024$11.0K$5.75M−$5.74M
Dec 2023$9.00K$5.63M−$5.62M
Dec 2022$88.6K$10.3M−$10.2M
Dec 2021$87.8K$3.21M−$3.13M
Dec 2020$165K$1.28M−$1.11M
Dec 2019$166K$1.30M−$1.13M
Dec 2018$124K$1.24M−$1.11M
Dec 2017$4.80K$1.18M−$1.18M
Dec 2016$0.00$760K−$760K